23Nov/18
FDA Grants Orphan Drug Designation to STRO-001 (ADC) by Sutro
Recently, Sutro Biopharma announced that the US Food and Drug Administration (FDA) has granted STRO-001 the orphan drug qualification for the treatment of multiple myeloma (MM). STRO-001 is a potential first antibodyRead More…